Striverdi Respimat Solution for Inhalation 2.5 microgram actuation Singapore - English - HSA (Health Sciences Authority)

striverdi respimat solution for inhalation 2.5 microgram actuation

boehringer ingelheim singapore pte. ltd. - olodaterol hydrochloride 2.7 mcg eqv olodaterol - solution - 2.5 mcg/actuation - olodaterol hydrochloride 2.7 mcg eqv olodaterol 2.5 mcg/actuation

Striverdi Respimat 2.5 microgram Inhalation solution Malta - English - Medicines Authority

striverdi respimat 2.5 microgram inhalation solution

boehringer ingelheim international gmbh binger strasse 173, 55216 ingelheim am rhein, germany - olodaterol - pressurised inhalation, solution - olodaterol 2.5 µg - drugs for obstructive airway diseases

Striverdi Respimat 2.5 microgram inhalation solution Ireland - English - HPRA (Health Products Regulatory Authority)

striverdi respimat 2.5 microgram inhalation solution

boehringer ingelheim international gmbh - olodaterol - inhalation solution - 2.5 microgram(s) - olodaterol

Striverdi Respimat New Zealand - English - Medsafe (Medicines Safety Authority)

striverdi respimat

boehringer ingelheim (nz) ltd - olodaterol hydrochloride 2.7ug equivalent to olodaterol 2.5 mcg - solution for inhalation - 2.5 mcg/dose - active: olodaterol hydrochloride 2.7ug equivalent to olodaterol 2.5 mcg excipient: benzalkonium chloride citric acid disodium edetate purified water - striverdi respimat is a long-acting beta 2 agonist indicated for once daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd).